VBIOValion Bio, Inc.vs its industry peers
A metric-by-metric comparison of Valion Bio, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VBIOThis | $12M#8 | — | 2.8x#12 | 15.2x#7 | -33.7%#8 | -57.0%#11 | -1012.6%#7 | -209.1%#10 | — | — | -99.1%#3 | — |
| RKTO | $13M#1 | — | 1.6x#10 | — | — | -52.3%#10 | — | -152.0%#6 | — | — | — | — |
| BFRI | $13M#2 | — | 2.1x#11 | 0.3x#1 | 11.7%#5 | 40.7%#4 | -27.2%#2 | -176.9%#7 | -712.4%#5 | — | — | — |
| KTTA | $13M#3 | — | 0.3x#1 | 26.1x#9 | 3130.4%#2 | -46.9%#9 | -4286.7%#10 | -41.0%#2 | — | — | — | — |
| BOLT | $13M#4 | — | 1.0x#6 | 1.6x#4 | 0.1%#7 | 47.1%#3 | -469.3%#4 | -264.1%#13 | — | — | — | — |
| KAPA | $13M#5 | — | 3.0x#13 | — | — | -109.3%#12 | — | -130.0%#5 | — | — | — | — |
| HIND | $12M#6 | 0.0x#1 | 4.9x#14 | 38.6x#10 | 24.4%#3 | -609.0%#14 | -3269.4%#9 | -405.7%#15 | -226.2%#4 | — | — | — |
| LPCN | $12M#7 | — | 0.5x#4 | 6.0x#5 | -82.3%#10 | -96400.0%#16 | -524.7%#5 | -44.2%#3 | -52.6%#1 | — | — | — |
| PPCB | $12M#9 | — | 1.2x#8 | — | — | 68.0%#1 | — | -200.6%#8 | -176.3%#3 | — | — | — |
| CLRB | $11M#10 | — | 0.4x#2 | — | — | 51.1%#2 | — | -72.9%#4 | — | — | — | — |
| ASBP | $11M#11 | 0.0x#2 | 1.0x#5 | 1834.0x#11 | — | -1768.9%#15 | -312016.9%#11 | -208.2%#9 | — | — | — | — |
| SBFM | $11M#12 | 0.5x#3 | 0.4x#3 | 0.3x#2 | 4.1%#6 | -16.4%#7 | -17.2%#1 | -21.7%#1 | -63.1%#2 | — | — | — |
| BIVI | $11M#13 | — | 1.0x#7 | — | — | -25.8%#8 | — | -214.9%#11 | -1671.2%#6 | — | — | — |
| LIPO | $11M#14 | — | 7.1x#15 | 19.8x#8 | 19.3%#4 | -8.6%#6 | -947.2%#6 | -337.2%#14 | — | — | — | — |
| DARE | $11M#15 | — | — | 10.3x#6 | 10429.4%#1 | -230.9%#13 | -1315.5%#8 | — | — | — | -64.2%#1 | — |
| TVRD | $11M#16 | — | 1.3x#9 | 1.5x#3 | -66.0%#9 | 38.1%#5 | -374.8%#3 | -217.3%#12 | — | — | -83.0%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice